HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

X Luo Selected Research

ON09310

4/2008Celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 expression via GADD153/CHOP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


X Luo Research Topics

Disease

31Neoplasms (Cancer)
06/2021 - 01/2000
7Hemorrhage
01/2021 - 02/2007
7Neoplasm Metastasis (Metastasis)
01/2021 - 01/2001
6Atrial Fibrillation
01/2021 - 03/2016
6Infections
10/2017 - 01/2001
5Hepatocellular Carcinoma (Hepatoma)
05/2020 - 06/2000
5Breast Neoplasms (Breast Cancer)
11/2018 - 01/2000
4Liver Neoplasms (Liver Cancer)
07/2021 - 06/2015
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2021 - 11/2006
4Carcinogenesis
06/2021 - 01/2013
4Hypoxia (Hypoxemia)
05/2019 - 12/2000
4Insulin Resistance
04/2018 - 10/2009
4Carcinoma (Carcinomatosis)
01/2018 - 01/2000
3Osteoarthritis
01/2022 - 02/2011
3Mitochondrial Diseases (Mitochondrial Disease)
06/2021 - 05/2011
3Cognitive Dysfunction
02/2021 - 06/2003
3Wounds and Injuries (Trauma)
02/2021 - 10/2017
3Necrosis
02/2020 - 02/2007
3Syphilis
10/2019 - 01/2019
3Inflammation (Inflammations)
01/2018 - 02/2015
3Body Weight (Weight, Body)
09/2015 - 01/2012
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2014 - 05/2011
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2014 - 08/2009
3Ischemia
10/2001 - 12/2000
2Stevens-Johnson Syndrome (Lyell's Syndrome)
06/2022 - 02/2016
2Nasal Polyps (Nasal Polyp)
02/2022 - 02/2015
2Asthma (Bronchial Asthma)
02/2022 - 02/2015
2Dementia (Dementias)
02/2021 - 06/2003
2Stroke (Strokes)
01/2021 - 10/2018
2Lymphatic Metastasis
01/2021 - 01/2020
2Embolism (Embolus)
01/2021 - 10/2018
2Adenocarcinoma
07/2020 - 01/2015
2Esophageal Squamous Cell Carcinoma
01/2020 - 01/2001
2Neurosyphilis (General Paresis of the Insane)
01/2019 - 05/2015
2Chronic Kidney Failure (Chronic Renal Failure)
12/2017 - 12/2016
2Thrombosis (Thrombus)
01/2017 - 01/2015
2Glaucoma
02/2016 - 04/2001
2Obesity
01/2016 - 09/2015
2Type 2 Diabetes Mellitus (MODY)
06/2015 - 09/2007
2Ovarian Neoplasms (Ovarian Cancer)
05/2015 - 08/2013
2Schizophrenia (Dementia Praecox)
08/2014 - 08/2013
2Ataxia Telangiectasia (Louis Bar Syndrome)
06/2013 - 09/2011
2Lymphoma (Lymphomas)
02/2013 - 02/2009
2Hypoglycemia (Reactive Hypoglycemia)
04/2012 - 10/2001
2Cardiotoxicity
08/2009 - 01/2009

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
05/2020 - 01/2000
9Pharmaceutical PreparationsIBA
01/2018 - 09/2011
6CytokinesIBA
02/2020 - 10/2008
6MicroRNAs (MicroRNA)IBA
10/2017 - 01/2010
5AnticoagulantsIBA
01/2021 - 01/2017
5Indicators and Reagents (Reagents)IBA
01/2021 - 01/2000
5Glucose (Dextrose)FDA LinkGeneric
01/2016 - 10/2009
4Messenger RNA (mRNA)IBA
02/2020 - 11/2012
4CateninsIBA
01/2016 - 06/2015
4Imatinib Mesylate (Gleevec)FDA Link
01/2014 - 01/2009
4VNP 20009 (VNP20009)IBA
07/2001 - 01/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 02/2007
3Long Noncoding RNAIBA
06/2021 - 11/2018
3Cisplatin (Platino)FDA LinkGeneric
02/2021 - 01/2018
3Warfarin (Coumadin)FDA LinkGeneric
01/2021 - 01/2017
3Interleukin-6 (Interleukin 6)IBA
02/2020 - 09/2015
3EnzymesIBA
07/2019 - 02/2019
3Biomarkers (Surrogate Marker)IBA
07/2019 - 07/2010
3Immunoglobulins (Immunoglobulin)IBA
02/2019 - 02/2015
3Insulin (Novolin)FDA Link
04/2018 - 09/2000
3DNA (Deoxyribonucleic Acid)IBA
10/2017 - 04/2011
3Transcription Factors (Transcription Factor)IBA
01/2017 - 11/2006
3Phosphotransferases (Kinase)IBA
01/2016 - 09/2011
3Peptides (Polypeptides)IBA
01/2015 - 05/2011
2HLA-B59 antigenIBA
06/2022 - 02/2016
2HLA-B Antigens (HLA-B)IBA
06/2022 - 12/2017
2MethazolamideFDA LinkGeneric
06/2022 - 02/2016
2AndrogensIBA
06/2021 - 04/2001
2LipopolysaccharidesIBA
02/2020 - 01/2020
2AntigensIBA
10/2019 - 02/2016
2ImmunosorbentsIBA
07/2019 - 02/2019
2Phosphopyruvate Hydratase (Enolase)IBA
07/2019 - 06/2017
2Bile Acids and Salts (Bile Acids)IBA
07/2019 - 05/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2019 - 11/2006
2InterferonsIBA
11/2018 - 05/2001
2Biological ProductsIBA
11/2018 - 01/2017
2apixabanIBA
10/2018 - 01/2018
2DabigatranFDA Link
10/2018 - 01/2018
2RivaroxabanIBA
10/2018 - 01/2018
2Insulin-Like Growth Factor I (IGF-1)IBA
04/2018 - 09/2011
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2018 - 01/2015
2RNA (Ribonucleic Acid)IBA
02/2016 - 05/2001
2Small Interfering RNA (siRNA)IBA
10/2015 - 09/2011
2Blood Glucose (Blood Sugar)IBA
09/2015 - 02/2013
2LipidsIBA
09/2015 - 07/2001
2Matrix Metalloproteinases (MMPs)IBA
08/2015 - 11/2006
2Lysine (L-Lysine)FDA Link
06/2015 - 06/2015
2Celecoxib (Celebrex)FDA Link
02/2011 - 04/2008
2Glutamic Acid (Glutamate)FDA Link
10/2001 - 04/2001
2AcidsIBA
10/2001 - 12/2000

Therapy/Procedure

9Therapeutics
01/2019 - 01/2000
2Lymph Node Excision (Lymph Node Dissection)
01/2020 - 07/2019
2Kidney Transplantation
12/2017 - 10/2016
2Islets of Langerhans Transplantation
07/2014 - 10/2011
2Radiotherapy
03/2007 - 03/2001